February 2008 |
|
Grassley letter to pharmaceutical drug maker about notice of drug trial findings
|
|
Tax Relief Has Boosted Federal Revenue Base, is Separate from Entitlement Problem
|
|
Grassley Welcomes Realization about SCHIP Funding Needs, Seeks Explanation for Administration’s Dramatic Turn-around
|
|
Grassley: SEC Agrees to Conduct More Aggressive Oversight of Stock Exchanges
|
January 2008 |
|
Grassley: Senate Stimulus Bill Improves Upon the House Bill
|
|
Grassley: House Stimulus Bill Reveals Inconsistency on Benefits to Illegal Immigrants
|
|
Grassley Advances Consideration of Renewable Energy Tax Incentives
|
|
Senator Grassley’s floor statement regarding manipulating science and Avandia
|
|
Grassley Praises Committee-Passed Economic Stimulus Package
|
|
Senator Grassley’s letter to the President of U.S. Pharmaceuticals, GlaxoSmithKline
|
|
Grassley secures commitment from IRS nominee to consider veterans from Iraq, Afghanistan for vacant jobs at agency
|
|
Grassley comments on the American College of Cardiology clarifying its position on ezetimibe (Zetia)
|
|
Baucus, Grassley Write to 136 Colleges, Seek Details of Endowment Pay-outs, Student Aid
|
|
Sen. Grassley asks questions about controversy over delayed release of drug study involving Vytorin
|
|
Grassley: Stimulus Package Should Stress Investment, Not Just Spur Spending
|
|
Sen. Grassley’s comment on Oral Roberts University seeking accreditation from the Evangelical Council for Financial Accountability
|
|
Grassley comment on Inspector General Report on oversight of conflicts of interest with NIH grantees
|
|
Grassley: Commission’s Gas Tax Increase is Old, Cold Idea
|
|
Grassley Welcomes Yale’s Increased Student Aid, Hopes Other Colleges Will Follow Suit
|
|
EU Foot-dragging on Ag Biotech Harms U.S. Producers, Violates Trade Obligations
|